Market Information

Market Information

Overview of Global Pharmaceutical Market

Global gross sales of pharmaceutical products and share of biologics

Actual 2006-2014 / Forecast 2015-2020

Biologics Market Expansion

Top 20 sales and share of biologics in global market

- Sales and its proportion of off-patent biologics -

Breakdown of top 20 sales of biologics / small molecular pharmaceuticals ( # of products)

2008
(Actual)
2014
(Actual)
2020
(Forecast)
Biologics 7 10 12
Off-patent biologics 0 0 8
Small molecular pharmaceuticals 13 10 8

Top Selling Products in the World

2016: Top Selling Products in the World

  • Biologics
  • Product under development
Rank Product Generic Name Pharmacological Class Company WW Product Sales ($bn)
1 Humira adalimumab Anti-tumour necrosis factor alpha (TNFa) MAb AbbVie + Eisai 16,515
2 Enbrel etanercept Tumour necrosis factor alpha (TNFa) inhibitor Amgen / Pfizer / Takeda 9,248
3 Harvoni sofosbuvir + ledipasvir Hepatitis C Gilead Sciences 9,081
4 Remicade infliximab Anti-tumour necrosis factor alpha (TNFa) MAb JNJ / Merck & Co / Mitsubishi Tanabe 8,070
5 Lantus insulin glargine recombinant Insulin analogue Sanofi 8,027
6 Rituxan rituximab Anti-CD20 MAb Biogen / Roche / Chugai 7,482
7 Revlimid lenalidomide Immunomodulator Celgene 6,974
8 Avastin bevacizumab Anti-VEGF MAb Genentech / Roche / Chugai 6,885
9 Herceptin trastuzumab Anti-HER2 (ErbB-2) MAb Genentech / Roche / Chugai 6,884
10 Januvia Sitagliptin Phosphate Dipeptidyl peptidase IV (DPP-IV) inhibitor Merck & Co 6,440